4.4 Article

Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS

Journal

NEUROSCIENCE LETTERS
Volume 759, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2021.136039

Keywords

Amyotrophic lateral sclerosis; Cortical hyperexcitability; Threshold tracking TMS

Categories

Funding

  1. National Health and Medical Research Council of Australia [510233, 1024915, 1055778]
  2. Motor Neuron Disease Research Institute of Australia
  3. Fight MND

Ask authors/readers for more resources

Cortical hyperexcitability is an early and intrinsic feature of ALS, associated with motor neuron degeneration. TMS is a non-invasive tool that can diagnose ALS accurately in early stages.
Cortical hyperexcitability is an early and intrinsic feature of both sporadic and familial forms of amyotrophic lateral sclerosis (ALS).. Importantly, cortical hyperexcitability appears to be associated with motor neuron degeneration, possibly via an anterograde glutamate-mediated excitotoxic process, thereby forming a pathogenic basis for ALS. The presence of cortical hyperexcitability in ALS patients may be readily determined by transcranial magnetic stimulation (TMS), a neurophysiological tool that provides a non-invasive and painless method for assessing cortical function. Utilising the threshold tracking TMS technique, cortical hyperexcitability has been established as a robust diagnostic biomarker that distinguished ALS from mimicking disorders at early stages of the disease process. The present review discusses the pathophysiological and diagnostic utility of cortical hyperexcitability in ALS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available